+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

  • PDF Icon

    SWOT Analysis

  • 49 Pages
  • January 2024
  • MarketLine
  • ID: 5743251
Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis or ‘the company’) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer’s, Huntington’s, and Parkinson’s disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington’s disease. Ionis uses antisense technology in the development of its drugs. It primarily operates in the US. The company is headquartered in Carlsbad, California, the US.

Scope

  • Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
  • Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

  • Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

  • Company Snapshot
  • Ionis Pharmaceuticals, Inc.: Company Overview
  • Ionis Pharmaceuticals, Inc.: Overview and Key Facts
  • Ionis Pharmaceuticals, Inc.: Overview
  • Ionis Pharmaceuticals, Inc.: Key Facts
  • Ionis Pharmaceuticals, Inc.: Key Employees
  • Ionis Pharmaceuticals, Inc.: Key Employee Biographies
  • Ionis Pharmaceuticals, Inc.: Major Products and Services
  • Ionis Pharmaceuticals, Inc.: Management Statement
  • Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
  • Ionis Pharmaceuticals, Inc.: Key Competitors
  • Ionis Pharmaceuticals, Inc.: Company Analysis
  • Ionis Pharmaceuticals, Inc.: Business Description
  • Ionis Pharmaceuticals, Inc.: SWOT Analysis
  • Ionis Pharmaceuticals, Inc.: SWOT Overview
  • Ionis Pharmaceuticals, Inc.: Strengths
  • Ionis Pharmaceuticals, Inc.: Weaknesses
  • Ionis Pharmaceuticals, Inc.: Opportunities
  • Ionis Pharmaceuticals, Inc.: Threats
  • Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
  • Ionis Pharmaceuticals, Inc.: Financial Deals Overview
  • Ionis Pharmaceuticals, Inc.: Targets and Partners
  • Ionis Pharmaceuticals, Inc.: Top Deals 2020 - 2024YTD*
  • Ionis Pharmaceuticals, Inc.: Advisors
  • Ionis Pharmaceuticals, Inc.: Top Legal Advisors
  • Ionis Pharmaceuticals, Inc.: Top Financial Advisors
  • Ionis Pharmaceuticals, Inc.: Mergers and Acquisitions
  • Ionis Pharmaceuticals, Inc.: Corporate Venturing
  • Ionis Pharmaceuticals, Inc.: Capital Raising
  • Ionis Pharmaceuticals, Inc.: Partnership
  • Ionis Pharmaceuticals, Inc.: Divestments
  • Ionis Pharmaceuticals, Inc.: Recent Developments
  • Ionis Pharmaceuticals, Inc.: News and Events Summary
  • Ionis Pharmaceuticals, Inc.: Contracts
  • Ionis Pharmaceuticals, Inc.: Corporate Governance
  • Ionis Pharmaceuticals, Inc.: Financial Performance
  • Ionis Pharmaceuticals, Inc.: Market Developments
  • Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
  • Ionis Pharmaceuticals, Inc.: Research & Development
  • Appendix
  • Contact the Publisher
  • Methodology
  • About the Publisher
List of Tables
  • Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
  • Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
  • Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
  • Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors
  • Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
  • Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
  • Table 7: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
  • Table 8: Ionis Pharmaceuticals, Inc.: Targets and Partners
  • Table 9: Ionis Pharmaceuticals, Inc.: Top Deals 2020 - 2024YTD*
  • Table 10: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
  • Table 11: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
  • Table 12: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
  • Table 13: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2020 - YTD*2024)
  • Table 14: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
  • Table 15: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
  • Table 16: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
  • Table 17: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
  • Table 18: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
  • Table 19: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
  • Table 20: Ionis Pharmaceuticals, Inc.: News and Events Summary
  • Table 21: Ionis Pharmaceuticals, Inc.: Contracts
  • Table 22: Ionis Pharmaceuticals, Inc.: Corporate Governance
  • Table 23: Ionis Pharmaceuticals, Inc.: Financial Performance
  • Table 24: Ionis Pharmaceuticals, Inc.: Market Developments
  • Table 25: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
  • Table 26: Ionis Pharmaceuticals, Inc.: Research & Development
List of Figures
  • Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
  • Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
  • Figure 3: Ionis Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
  • Figure 4: Ionis Pharmaceuticals, Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
  • Figure 5: Ionis Pharmaceuticals, Inc.: M&A Activity by Geography (2020 - YTD*2024)
  • Figure 6: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
  • Figure 7: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
  • Figure 8: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
  • Figure 9: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
  • Figure 10: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
  • Figure 11: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)